Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport intradermal proof-of-concept study for chronic abdominal or thoracic scar pain
2018-001703-37Phase 2Completed
- Sponsor
- Ipsen
- Start
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Postsurgical Neuralgia and Neuralgia comparing Dysport intradermal dose arm(s) with Placebo (2 arms). Primary endpoint: Pharmacodynamic analgesic profile based on Numerical Rating Score. Started Aug 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Postsurgical NeuralgiaNeuralgia
Beyond the preview
Go deeper on 2018-001703-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001703-37.